{"data":{"id":"us-ut/utah-code-58-37-109","jurisdiction":"us-ut","citation":"Utah Code § 58-37-109","heading":"Listed controlled substances.","body":"The following substances, their analogs, homologs, and synthetic equivalents, are listed controlled substances:\n(1) AB-001;\n(2) AB-PINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;\n(3) AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide;\n(4) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);\n(5) ADB-CHMINACA (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)indazole-3-carboxamide);\n(6) ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1- (4-fluorobenzyl)-1H-indazole-3-caboxamide);\n(7) AKB48;\n(8) alpha-Pyrrolidinohexanophenone (alpha-PHP) (1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one);\n(9) alpha-Pyrrolidinovalerophenone (alpha-PVP);\n(10) AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone);\n(11) AM-1248;\n(12) AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole);\n(13) AM-2233;\n(14) AM-679;\n(15) A796,260;\n(16) Butylone;\n(17) CP 47,497 and its C6, C8, and C9 homologs (2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol);\n(18) Diisopropyltryptamine (DiPT);\n(19) Ethylone;\n(20) Ethylphenidate;\n(21) Fluoroisocathinone;\n(22) Fluoromethamphetamine;\n(23) Fluoromethcathinone;\n(24) FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate;\n(25) HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;\n(26) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-\nmethyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;\n(27) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;\n(28) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-naphthoyl)indole};\n(29) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;\n(30) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as 1-Butyl-3-(1-naphthoyl)indole};\n(31) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;\n(32) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);\n(33) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;\n(34) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;\n(35) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;\n(36) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;\n(37) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;\n(38) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;\n(39) MAM-2201;\n(40) MAM-2201; (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;\n(41) Methoxetamine;\n(42) Naphyrone;\n(43) PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;\n(44) Pentedrone;\n(45) Pentylone;\n(46) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;\n(47) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also known as BTW-8 and SR-18};\n(48) STS-135;\n(49) UR-144;\n(50) UR-144 N-(5-chloropentyl) analog;\n(51) XLR11;\n(52) 2C-C;\n(53) 2C-D;\n(54) 2C-E;\n(55) 2C-H;\n(56) 2C-I;\n(57) 2C-N;\n(58) 2C-P;\n(59) 2C-T-2;\n(60) 2C-T-4;\n(61) 2NE1;\n(62) 25I-NBOMe;\n(63) 2,5-Dimethoxy-4-chloroamphetamine (DOC);\n(64) 4-Fluoro MDMB-BUTINACA (Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate);\n(65) 4-methylmethcathinone {also known as mephedrone};\n(66) 3,4-methylenedioxypyrovalerone {also known as MDPV};\n(67) 3,4-Methylenedioxymethcathinone {also known as methylone};\n(68) 4-methoxymethcathinone;\n(69) 4-Methyl-alpha-pyrrolidinopropiophenone;\n(70) 4-Methylethcathinone;\n(71) 5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;\n(72) 5-Fluoro ADB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}-3-methyl-valinate);\n(73) 5-Fluoro AMB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate);\n(74) 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;\n(75) 5-Iodo-2-aminoindane (5-IAI);\n(76) 5-MeO-DALT;\n(77) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;\n(78) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; and\n(79) 25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.","path":["Title 58 Occupations and Professions","Chapter 58-37 Controlled Substances","Part 58-37-1 General Provisions"],"source_url":"https://le.utah.gov/xcode/Title58/Chapter37/58-37-S109.html","current_through":"2026 General Session","vintage":"","retrieved_at":"2026-09-03T11:34:33Z","sha256":"d492ead3bbcb27db25b509046a9b297a0e9cf92d48388b3179e3b5731d3aa61a","source_id":"us-ut","stale":false,"prev":"us-ut/utah-code-58-37-108","next":"us-ut/utah-code-58-37-110"},"notice":"GroundRules: Original legal text. Not legal advice."}